Back
Delegates Premium Access

Ejection fraction as challenge in cardio-oncology: metastatic RCC in a patient with severe cardiotoxic cardiomyopathy and end stage renal failure in remission after DLBCL and R-CHOP therapy

Session: From the clinic to Florence: experiences at the frontline of cardio-oncology (2)
Topic: Cardio-Oncology
Speaker: Doctor A. Spannbauer (Vienna, AT)
Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Andreas Spannbauer

Medical University of Vienna, Vienna (Austria)
1 presentation
0 follower

6 more presentations in this session

Cancer-induced marantic endocarditis with severe valvular destruction successfully treated with aortic valve replacement and transcatheter mitral repair in a young patient with lung adenocarcinoma

Speaker: Doctor L. Hauptmann (Vienna, AT)

Access
Slides
Video
Like
Thumbnail

Chemotherapy-related cardiotoxicity beyond cancer treatment: A hidden threat

Speaker: Doctor D. Arcese (Florence, IT)

Access
Slides
Video
Like
Thumbnail

Utilizing CMR parametric mapping to diagnose and monitor progressive LVH in acute lymphoblastic leukemia relapse treated with CAR-T therapy

Speaker: Doctor M. Jung (Seoul, KR)

Access
Slides
Video
Like
Thumbnail

Simultaneous transcatheter pulmonary and tricuspid valve replacement in carcinoid heart disease.

Speaker: Professor J. Bergler-Klein (Vienna, AT)

Access
Slides
Video
Like
Thumbnail

Immune checkpoint inhibitor-induced myocarditis with atrioventricular conduction abnormalities

Speaker: Miss A. Strijdhorst (Amsterdam, NL)

Access
Slides
Video
Like
Thumbnail

Access the full session

From the clinic to Florence: experiences at the frontline of cardio-oncology (2)

Speakers: Doctor A. Spannbauer, Doctor L. Hauptmann, Doctor D. Arcese, Doctor M. Jung, Professor J. Bergler-Klein...
Access
Like
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources